Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

June 01, 2005; Volume 33,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abe, Daisuke

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
  2. Anzenbacher, Pavel

    1. You have access
      MINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYME
      Jana Baranová, Eva Anzenbacherová, Pavel Anzenbacher and Pavel Souček
      Drug Metabolism and Disposition June 2005, 33 (6) 862-865; DOI: https://doi.org/10.1124/dmd.104.003392
  3. Anzenbacherová, Eva

    1. You have access
      MINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYME
      Jana Baranová, Eva Anzenbacherová, Pavel Anzenbacher and Pavel Souček
      Drug Metabolism and Disposition June 2005, 33 (6) 862-865; DOI: https://doi.org/10.1124/dmd.104.003392
  4. Arthaud, Larry

    1. You have access
      THE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATS
      Peter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. Rose
      Drug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592
  5. Attaccalite, Silvia

    1. You have access
      DETERMINATION OF DRUG GLUCURONIDATION AND UDP-GLUCURONOSYLTRANSFERASE SELECTIVITY USING A 96-WELL RADIOMETRIC ASSAY
      Annalise Di Marco, Michelle D'Antoni, Silvia Attaccalite, Pietro Carotenuto and Ralph Laufer
      Drug Metabolism and Disposition June 2005, 33 (6) 812-819; DOI: https://doi.org/10.1124/dmd.105.004333

B

  1. Baranová, Jana

    1. You have access
      MINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYME
      Jana Baranová, Eva Anzenbacherová, Pavel Anzenbacher and Pavel Souček
      Drug Metabolism and Disposition June 2005, 33 (6) 862-865; DOI: https://doi.org/10.1124/dmd.104.003392
  2. Baronas, Elizabeth

    1. You have access
      HUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITES
      Teresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald Miwa
      Drug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
  3. Baughman, T. M.

    1. You have access
      METABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTES
      T. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. Zhao
      Drug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
  4. Bonate, Peter L.

    1. You have access
      THE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATS
      Peter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. Rose
      Drug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592
  5. Bumpus, Namandjé N.

    1. You have access
      THE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATION
      Namandjé N. Bumpus, Chitra Sridar, Ute M. Kent and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2005, 33 (6) 795-802; DOI: https://doi.org/10.1124/dmd.105.003749
  6. Burczynski, Frank J.

    1. You have access
      METABOLISM OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE AND ONE OF ITS METABOLITES BY ISOLATED RAT MYOCYTES, HEPATOCYTES, AND BLOOD
      Patricia E. Schroeder, Gu-Qi Wang, Frank J. Burczynski and Brian B. Hasinoff
      Drug Metabolism and Disposition June 2005, 33 (6) 719-725; DOI: https://doi.org/10.1124/dmd.104.003186

C

  1. Caldwell, Gary W.

    1. You have access
      DETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDES
      Zhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua Zhong
      Drug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095
  2. Carotenuto, Pietro

    1. You have access
      DETERMINATION OF DRUG GLUCURONIDATION AND UDP-GLUCURONOSYLTRANSFERASE SELECTIVITY USING A 96-WELL RADIOMETRIC ASSAY
      Annalise Di Marco, Michelle D'Antoni, Silvia Attaccalite, Pietro Carotenuto and Ralph Laufer
      Drug Metabolism and Disposition June 2005, 33 (6) 812-819; DOI: https://doi.org/10.1124/dmd.105.004333
  3. Chen, Xiaoyan

    1. You have access
      ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS
      Yingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui Zhou
      Drug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
  4. Choi, Man Ho

    1. You have access
      CHARACTERIZATION OF TESTOSTERONE 11β-HYDROXYLATION CATALYZED BY HUMAN LIVER MICROSOMAL CYTOCHROMES P450
      Man Ho Choi, Paul L. Skipper, John S. Wishnok and Steven R. Tannenbaum
      Drug Metabolism and Disposition June 2005, 33 (6) 714-718; DOI: https://doi.org/10.1124/dmd.104.003327

D

  1. D'Antoni, Michelle

    1. You have access
      DETERMINATION OF DRUG GLUCURONIDATION AND UDP-GLUCURONOSYLTRANSFERASE SELECTIVITY USING A 96-WELL RADIOMETRIC ASSAY
      Annalise Di Marco, Michelle D'Antoni, Silvia Attaccalite, Pietro Carotenuto and Ralph Laufer
      Drug Metabolism and Disposition June 2005, 33 (6) 812-819; DOI: https://doi.org/10.1124/dmd.105.004333
  2. Daniels, J. Scott

    1. You have access
      HUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITES
      Teresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald Miwa
      Drug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
  3. Di Marco, Annalise

    1. You have access
      DETERMINATION OF DRUG GLUCURONIDATION AND UDP-GLUCURONOSYLTRANSFERASE SELECTIVITY USING A 96-WELL RADIOMETRIC ASSAY
      Annalise Di Marco, Michelle D'Antoni, Silvia Attaccalite, Pietro Carotenuto and Ralph Laufer
      Drug Metabolism and Disposition June 2005, 33 (6) 812-819; DOI: https://doi.org/10.1124/dmd.105.004333
  4. Du, Yanming

    1. You have access
      DETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDES
      Zhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua Zhong
      Drug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095
  5. Duan, Su X.

    1. You have access
      ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO
      Elke S. Perloff, Su X. Duan, Paul R. Skolnik, David J. Greenblatt and Lisa L. von Moltke
      Drug Metabolism and Disposition June 2005, 33 (6) 764-770; DOI: https://doi.org/10.1124/dmd.104.002931

F

  1. Fawcett, J. Paul

    1. You have access
      ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS
      Yingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui Zhou
      Drug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
  2. Fujishima, Toshie

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038

G

  1. Gan, Liang-Shang

    1. You have access
      HUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITES
      Teresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald Miwa
      Drug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
  2. Graham, R. A.

    1. You have access
      METABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTES
      T. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. Zhao
      Drug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
  3. Greenblatt, David J.

    1. You have access
      ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO
      Elke S. Perloff, Su X. Duan, Paul R. Skolnik, David J. Greenblatt and Lisa L. von Moltke
      Drug Metabolism and Disposition June 2005, 33 (6) 764-770; DOI: https://doi.org/10.1124/dmd.104.002931
  4. Gunnarsson, Per Olov

    1. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR
      Helén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric Seidegård
      Drug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
  5. Guo, Yingjie

    1. You have access
      ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS
      Yingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui Zhou
      Drug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
  6. Gupta, Anshul

    1. You have access
      FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620N
      R. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng Mao
      Drug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657

H

  1. Hallifax, David

    1. You have access
      IMPACT OF PARALLEL PATHWAYS OF DRUG ELIMINATION AND MULTIPLE CYTOCHROME P450 INVOLVEMENT ON DRUG-DRUG INTERACTIONS: CYP2D6 PARADIGM
      Kiyomi Ito, David Hallifax, R. Scott Obach and J. Brian Houston
      Drug Metabolism and Disposition June 2005, 33 (6) 837-844; DOI: https://doi.org/10.1124/dmd.105.003715
  2. Hallin, Ingrid

    1. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR
      Helén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric Seidegård
      Drug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
  3. Hamamoto, Hiromi

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
  4. Hartmann, Georgy

    1. You have access
      IMPACT OF ENDOTOXIN-INDUCED CHANGES IN P-GLYCOPROTEIN EXPRESSION ON DISPOSITION OF DOXORUBICIN IN MICE
      Georgy Hartmann, Vessela Vassileva and Micheline Piquette-Miller
      Drug Metabolism and Disposition June 2005, 33 (6) 820-828; DOI: https://doi.org/10.1124/dmd.104.002568
  5. Hasinoff, Brian B.

    1. You have access
      METABOLISM OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE AND ONE OF ITS METABOLITES BY ISOLATED RAT MYOCYTES, HEPATOCYTES, AND BLOOD
      Patricia E. Schroeder, Gu-Qi Wang, Frank J. Burczynski and Brian B. Hasinoff
      Drug Metabolism and Disposition June 2005, 33 (6) 719-725; DOI: https://doi.org/10.1124/dmd.104.003186
  6. Hollenberg, Paul F.

    1. You have access
      THE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATION
      Namandjé N. Bumpus, Chitra Sridar, Ute M. Kent and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2005, 33 (6) 795-802; DOI: https://doi.org/10.1124/dmd.105.003749
  7. Horie, Toru

    1. You have access
      IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
  8. Horie, Toshiharu

    1. You have access
      ACYL GLUCURONIDATION OF FLUOROQUINOLONE ANTIBIOTICS BY THE UDP-GLUCURONOSYLTRANSFERASE 1A SUBFAMILY IN HUMAN LIVER MICROSOMES
      Masaya Tachibana, Makoto Tanaka, Yasuhiro Masubuchi and Toshiharu Horie
      Drug Metabolism and Disposition June 2005, 33 (6) 803-811; DOI: https://doi.org/10.1124/dmd.104.003178
  9. Houston, J. Brian

    1. You have access
      IMPACT OF PARALLEL PATHWAYS OF DRUG ELIMINATION AND MULTIPLE CYTOCHROME P450 INVOLVEMENT ON DRUG-DRUG INTERACTIONS: CYP2D6 PARADIGM
      Kiyomi Ito, David Hallifax, R. Scott Obach and J. Brian Houston
      Drug Metabolism and Disposition June 2005, 33 (6) 837-844; DOI: https://doi.org/10.1124/dmd.105.003715
  10. Hsieh, Frank

    1. You have access
      HUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITES
      Teresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald Miwa
      Drug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
  11. Hu, Ming

    1. You have access
      SPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10
      Eun Ju Jeong, Yong Liu, Huimin Lin and Ming Hu
      Drug Metabolism and Disposition June 2005, 33 (6) 785-794; DOI: https://doi.org/10.1124/dmd.104.001883
  12. Huebert, Norman

    1. You have access
      DETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDES
      Zhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua Zhong
      Drug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095

I

  1. Inouye, Kuniyo

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
  2. Ito, Kiyomi

    1. You have access
      IMPACT OF PARALLEL PATHWAYS OF DRUG ELIMINATION AND MULTIPLE CYTOCHROME P450 INVOLVEMENT ON DRUG-DRUG INTERACTIONS: CYP2D6 PARADIGM
      Kiyomi Ito, David Hallifax, R. Scott Obach and J. Brian Houston
      Drug Metabolism and Disposition June 2005, 33 (6) 837-844; DOI: https://doi.org/10.1124/dmd.105.003715
  3. Iwaki, Masahiro

    1. You have access
      NONLINEAR PHARMACOKINETICS OF PROPAFENONE IN RATS AND HUMANS: APPLICATION OF A SUBSTRATE DEPLETION ASSAY USING HEPATOCYTES FOR ASSESSMENT OF NONLINEARITY
      Hiroshi Komura and Masahiro Iwaki
      Drug Metabolism and Disposition June 2005, 33 (6) 726-732; DOI: https://doi.org/10.1124/dmd.104.002550
  4. Iwasaki, Kazuhide

    1. You have access
      IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600

J

  1. Jeong, Eun Ju

    1. You have access
      SPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10
      Eun Ju Jeong, Yong Liu, Huimin Lin and Ming Hu
      Drug Metabolism and Disposition June 2005, 33 (6) 785-794; DOI: https://doi.org/10.1124/dmd.104.001883

K

  1. Kamakura, Masaki

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
  2. Katoh, Miki

    1. You have access
      IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
  3. Kent, Ute M.

    1. You have access
      THE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATION
      Namandjé N. Bumpus, Chitra Sridar, Ute M. Kent and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2005, 33 (6) 795-802; DOI: https://doi.org/10.1124/dmd.105.003749
  4. Kittaka, Atsushi

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
  5. Komura, Hiroshi

    1. You have access
      NONLINEAR PHARMACOKINETICS OF PROPAFENONE IN RATS AND HUMANS: APPLICATION OF A SUBSTRATE DEPLETION ASSAY USING HEPATOCYTES FOR ASSESSMENT OF NONLINEARITY
      Hiroshi Komura and Masahiro Iwaki
      Drug Metabolism and Disposition June 2005, 33 (6) 726-732; DOI: https://doi.org/10.1124/dmd.104.002550
  6. Kunze, Kent L.

    1. You have access
      EVALUATION OF TIME-DEPENDENT INACTIVATION OF CYP3A IN CRYOPRESERVED HUMAN HEPATOCYTES
      Ping Zhao, Kent L. Kunze and Caroline A. Lee
      Drug Metabolism and Disposition June 2005, 33 (6) 853-861; DOI: https://doi.org/10.1124/dmd.104.002832
  7. Kusudo, Tatsuya

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038

L

  1. Labutti, Jason

    1. You have access
      HUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITES
      Teresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald Miwa
      Drug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
  2. Laufer, Ralph

    1. You have access
      DETERMINATION OF DRUG GLUCURONIDATION AND UDP-GLUCURONOSYLTRANSFERASE SELECTIVITY USING A 96-WELL RADIOMETRIC ASSAY
      Annalise Di Marco, Michelle D'Antoni, Silvia Attaccalite, Pietro Carotenuto and Ralph Laufer
      Drug Metabolism and Disposition June 2005, 33 (6) 812-819; DOI: https://doi.org/10.1124/dmd.105.004333
  3. Lee, Caroline A.

    1. You have access
      EVALUATION OF TIME-DEPENDENT INACTIVATION OF CYP3A IN CRYOPRESERVED HUMAN HEPATOCYTES
      Ping Zhao, Kent L. Kunze and Caroline A. Lee
      Drug Metabolism and Disposition June 2005, 33 (6) 853-861; DOI: https://doi.org/10.1124/dmd.104.002832
  4. Lewis, Fred

    1. You have access
      FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620N
      R. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng Mao
      Drug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
  5. Li, Jian

    1. You have access
      DETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDES
      Zhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua Zhong
      Drug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095
  6. Lin, Huimin

    1. You have access
      SPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10
      Eun Ju Jeong, Yong Liu, Huimin Lin and Ming Hu
      Drug Metabolism and Disposition June 2005, 33 (6) 785-794; DOI: https://doi.org/10.1124/dmd.104.001883
  7. Liu, Yong

    1. You have access
      SPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10
      Eun Ju Jeong, Yong Liu, Huimin Lin and Ming Hu
      Drug Metabolism and Disposition June 2005, 33 (6) 785-794; DOI: https://doi.org/10.1124/dmd.104.001883

M

  1. Mao, Qingcheng

    1. You have access
      FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620N
      R. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng Mao
      Drug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
  2. Masubuchi, Yasuhiro

    1. You have access
      ACYL GLUCURONIDATION OF FLUOROQUINOLONE ANTIBIOTICS BY THE UDP-GLUCURONOSYLTRANSFERASE 1A SUBFAMILY IN HUMAN LIVER MICROSOMES
      Masaya Tachibana, Makoto Tanaka, Yasuhiro Masubuchi and Toshiharu Horie
      Drug Metabolism and Disposition June 2005, 33 (6) 803-811; DOI: https://doi.org/10.1124/dmd.104.003178
  3. Matsui, Tomohito

    1. You have access
      IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
  4. Mehvar, Reza

    1. You have access
      ENZYME-SELECTIVE EFFECTS OF NITRIC OXIDE ON AFFINITY AND MAXIMUM VELOCITY OF VARIOUS RAT CYTOCHROMES P450
      Ragini Vuppugalla and Reza Mehvar
      Drug Metabolism and Disposition June 2005, 33 (6) 829-836; DOI: https://doi.org/10.1124/dmd.105.003848
  5. Miwa, Gerald

    1. You have access
      HUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITES
      Teresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald Miwa
      Drug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956

N

  1. Nakajima, Miki

    1. You have access
      IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
  2. Nix, Darrell

    1. You have access
      HUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITES
      Teresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald Miwa
      Drug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956

O

  1. Obach, R. Scott

    1. You have access
      IMPACT OF PARALLEL PATHWAYS OF DRUG ELIMINATION AND MULTIPLE CYTOCHROME P450 INVOLVEMENT ON DRUG-DRUG INTERACTIONS: CYP2D6 PARADIGM
      Kiyomi Ito, David Hallifax, R. Scott Obach and J. Brian Houston
      Drug Metabolism and Disposition June 2005, 33 (6) 837-844; DOI: https://doi.org/10.1124/dmd.105.003715
    2. You have access
      IN VITRO-IN VIVO EXTRAPOLATION OF CYP2D6 INACTIVATION BY PAROXETINE: PREDICTION OF NONSTATIONARY PHARMACOKINETICS AND DRUG INTERACTION MAGNITUDE
      Karthik Venkatakrishnan and R. Scott Obach
      Drug Metabolism and Disposition June 2005, 33 (6) 845-852; DOI: https://doi.org/10.1124/dmd.105.004077
  2. Ohta, Miho

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038

P

  1. Parsons, Ian

    1. You have access
      HUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITES
      Teresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald Miwa
      Drug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
  2. Pekol, Teresa

    1. You have access
      HUMAN METABOLISM OF THE PROTEASOME INHIBITOR BORTEZOMIB: IDENTIFICATION OF CIRCULATING METABOLITES
      Teresa Pekol, J. Scott Daniels, Jason Labutti, Ian Parsons, Darrell Nix, Elizabeth Baronas, Frank Hsieh, Liang-Shang Gan and Gerald Miwa
      Drug Metabolism and Disposition June 2005, 33 (6) 771-777; DOI: https://doi.org/10.1124/dmd.104.002956
  3. Perloff, Elke S.

    1. You have access
      ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO
      Elke S. Perloff, Su X. Duan, Paul R. Skolnik, David J. Greenblatt and Lisa L. von Moltke
      Drug Metabolism and Disposition June 2005, 33 (6) 764-770; DOI: https://doi.org/10.1124/dmd.104.002931
  4. Persson, Robert

    1. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR
      Helén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric Seidegård
      Drug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
  5. Piquette-Miller, Micheline

    1. You have access
      IMPACT OF ENDOTOXIN-INDUCED CHANGES IN P-GLYCOPROTEIN EXPRESSION ON DISPOSITION OF DOXORUBICIN IN MICE
      Georgy Hartmann, Vessela Vassileva and Micheline Piquette-Miller
      Drug Metabolism and Disposition June 2005, 33 (6) 820-828; DOI: https://doi.org/10.1124/dmd.104.002568
  6. Press, Randall J.

    1. You have access
      THE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATS
      Peter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. Rose
      Drug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592

R

  1. Rose, James Q.

    1. You have access
      THE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATS
      Peter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. Rose
      Drug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592

S

  1. Saito, Nozomi

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
  2. Sakaki, Toshiyuki

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
  3. Schroeder, Patricia E.

    1. You have access
      METABOLISM OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE AND ONE OF ITS METABOLITES BY ISOLATED RAT MYOCYTES, HEPATOCYTES, AND BLOOD
      Patricia E. Schroeder, Gu-Qi Wang, Frank J. Burczynski and Brian B. Hasinoff
      Drug Metabolism and Disposition June 2005, 33 (6) 719-725; DOI: https://doi.org/10.1124/dmd.104.003186
  4. Seidegård, Janeric

    1. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR
      Helén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric Seidegård
      Drug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
  5. Si, Dayong

    1. You have access
      ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS
      Yingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui Zhou
      Drug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
  6. Silver, I. S.

    1. You have access
      METABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTES
      T. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. Zhao
      Drug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
  7. Skipper, Paul L.

    1. You have access
      CHARACTERIZATION OF TESTOSTERONE 11β-HYDROXYLATION CATALYZED BY HUMAN LIVER MICROSOMAL CYTOCHROMES P450
      Man Ho Choi, Paul L. Skipper, John S. Wishnok and Steven R. Tannenbaum
      Drug Metabolism and Disposition June 2005, 33 (6) 714-718; DOI: https://doi.org/10.1124/dmd.104.003327
  8. Skolnik, Paul R.

    1. You have access
      ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO
      Elke S. Perloff, Su X. Duan, Paul R. Skolnik, David J. Greenblatt and Lisa L. von Moltke
      Drug Metabolism and Disposition June 2005, 33 (6) 764-770; DOI: https://doi.org/10.1124/dmd.104.002931
  9. Soeno, Yoshinori

    1. You have access
      IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
  10. Souček, Pavel

    1. You have access
      MINIPIG CYTOCHROME P450 2E1: COMPARISON WITH HUMAN ENZYME
      Jana Baranová, Eva Anzenbacherová, Pavel Anzenbacher and Pavel Souček
      Drug Metabolism and Disposition June 2005, 33 (6) 862-865; DOI: https://doi.org/10.1124/dmd.104.003392
  11. Sparre, Birgitta

    1. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR
      Helén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric Seidegård
      Drug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
  12. Sridar, Chitra

    1. You have access
      THE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATION
      Namandjé N. Bumpus, Chitra Sridar, Ute M. Kent and Paul F. Hollenberg
      Drug Metabolism and Disposition June 2005, 33 (6) 795-802; DOI: https://doi.org/10.1124/dmd.105.003749
  13. Stuhler, John

    1. You have access
      THE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATS
      Peter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. Rose
      Drug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592
  14. Suhara, Yoshitomo

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038

T

  1. Tachibana, Masaya

    1. You have access
      ACYL GLUCURONIDATION OF FLUOROQUINOLONE ANTIBIOTICS BY THE UDP-GLUCURONOSYLTRANSFERASE 1A SUBFAMILY IN HUMAN LIVER MICROSOMES
      Masaya Tachibana, Makoto Tanaka, Yasuhiro Masubuchi and Toshiharu Horie
      Drug Metabolism and Disposition June 2005, 33 (6) 803-811; DOI: https://doi.org/10.1124/dmd.104.003178
  2. Takayama, Hiroaki

    1. You have access
      METABOLISM OF 2α-PROPOXY-1α,25-DIHYDROXYVITAMIN D3 AND 2α-(3-HYDROXYPROPOXY)-1α,25-DIHYDROXYVITAMIN D3 BY HUMAN CYP27A1 AND CYP24A1
      Daisuke Abe, Toshiyuki Sakaki, Tatsuya Kusudo, Atsushi Kittaka, Nozomi Saito, Yoshitomo Suhara, Toshie Fujishima, Hiroaki Takayama, Hiromi Hamamoto, Masaki Kamakura, Miho Ohta and Kuniyo Inouye
      Drug Metabolism and Disposition June 2005, 33 (6) 778-784; DOI: https://doi.org/10.1124/dmd.104.003038
  3. Tanaka, Makoto

    1. You have access
      ACYL GLUCURONIDATION OF FLUOROQUINOLONE ANTIBIOTICS BY THE UDP-GLUCURONOSYLTRANSFERASE 1A SUBFAMILY IN HUMAN LIVER MICROSOMES
      Masaya Tachibana, Makoto Tanaka, Yasuhiro Masubuchi and Toshiharu Horie
      Drug Metabolism and Disposition June 2005, 33 (6) 803-811; DOI: https://doi.org/10.1124/dmd.104.003178
  4. Tannenbaum, Steven R.

    1. You have access
      CHARACTERIZATION OF TESTOSTERONE 11β-HYDROXYLATION CATALYZED BY HUMAN LIVER MICROSOMAL CYTOCHROMES P450
      Man Ho Choi, Paul L. Skipper, John S. Wishnok and Steven R. Tannenbaum
      Drug Metabolism and Disposition June 2005, 33 (6) 714-718; DOI: https://doi.org/10.1124/dmd.104.003327
  5. Tateno, Chise

    1. You have access
      IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
  6. Tuvesson, Helén

    1. You have access
      CYTOCHROME P450 3A4 IS THE MAJOR ENZYME RESPONSIBLE FOR THE METABOLISM OF LAQUINIMOD, A NOVEL IMMUNOMODULATOR
      Helén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson and Janeric Seidegård
      Drug Metabolism and Disposition June 2005, 33 (6) 866-872; DOI: https://doi.org/10.1124/dmd.104.002238
  7. Tyler, L. O.

    1. You have access
      METABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTES
      T. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. Zhao
      Drug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683

U

  1. Unadkat, Jashvant D.

    1. You have access
      FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620N
      R. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng Mao
      Drug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657

V

  1. Vassileva, Vessela

    1. You have access
      IMPACT OF ENDOTOXIN-INDUCED CHANGES IN P-GLYCOPROTEIN EXPRESSION ON DISPOSITION OF DOXORUBICIN IN MICE
      Georgy Hartmann, Vessela Vassileva and Micheline Piquette-Miller
      Drug Metabolism and Disposition June 2005, 33 (6) 820-828; DOI: https://doi.org/10.1124/dmd.104.002568
  2. Venkatakrishnan, Karthik

    1. You have access
      IN VITRO-IN VIVO EXTRAPOLATION OF CYP2D6 INACTIVATION BY PAROXETINE: PREDICTION OF NONSTATIONARY PHARMACOKINETICS AND DRUG INTERACTION MAGNITUDE
      Karthik Venkatakrishnan and R. Scott Obach
      Drug Metabolism and Disposition June 2005, 33 (6) 845-852; DOI: https://doi.org/10.1124/dmd.105.004077
  3. Vethanayagam, R. Robert

    1. You have access
      FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620N
      R. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng Mao
      Drug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
  4. von Moltke, Lisa L.

    1. You have access
      ATAZANAVIR: EFFECTS ON P-GLYCOPROTEIN TRANSPORT AND CYP3A METABOLISM IN VITRO
      Elke S. Perloff, Su X. Duan, Paul R. Skolnik, David J. Greenblatt and Lisa L. von Moltke
      Drug Metabolism and Disposition June 2005, 33 (6) 764-770; DOI: https://doi.org/10.1124/dmd.104.002931
  5. Vuppugalla, Ragini

    1. You have access
      ENZYME-SELECTIVE EFFECTS OF NITRIC OXIDE ON AFFINITY AND MAXIMUM VELOCITY OF VARIOUS RAT CYTOCHROMES P450
      Ragini Vuppugalla and Reza Mehvar
      Drug Metabolism and Disposition June 2005, 33 (6) 829-836; DOI: https://doi.org/10.1124/dmd.105.003848

W

  1. Wang, Gu-Qi

    1. You have access
      METABOLISM OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE AND ONE OF ITS METABOLITES BY ISOLATED RAT MYOCYTES, HEPATOCYTES, AND BLOOD
      Patricia E. Schroeder, Gu-Qi Wang, Frank J. Burczynski and Brian B. Hasinoff
      Drug Metabolism and Disposition June 2005, 33 (6) 719-725; DOI: https://doi.org/10.1124/dmd.104.003186
  2. Wang, Honggang

    1. You have access
      FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620N
      R. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng Mao
      Drug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
  3. Wang, Ying

    1. You have access
      ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS
      Yingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui Zhou
      Drug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
  4. Wells-Knecht, K.

    1. You have access
      METABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTES
      T. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. Zhao
      Drug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
  5. Wells-Knecht, M.

    1. You have access
      METABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTES
      T. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. Zhao
      Drug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
  6. Wishnok, John S.

    1. You have access
      CHARACTERIZATION OF TESTOSTERONE 11β-HYDROXYLATION CATALYZED BY HUMAN LIVER MICROSOMAL CYTOCHROMES P450
      Man Ho Choi, Paul L. Skipper, John S. Wishnok and Steven R. Tannenbaum
      Drug Metabolism and Disposition June 2005, 33 (6) 714-718; DOI: https://doi.org/10.1124/dmd.104.003327

Y

  1. Yan, Zhengyin

    1. You have access
      DETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDES
      Zhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua Zhong
      Drug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095
  2. Yerino, Phyllis

    1. You have access
      THE DISTRIBUTION, METABOLISM, AND ELIMINATION OF CLOFARABINE IN RATS
      Peter L. Bonate, Larry Arthaud, John Stuhler, Phyllis Yerino, Randall J. Press and James Q. Rose
      Drug Metabolism and Disposition June 2005, 33 (6) 739-748; DOI: https://doi.org/10.1124/dmd.104.002592
  3. Yokoi, Tsuyoshi

    1. You have access
      IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600
  4. Yoshizato, Katsutoshi

    1. You have access
      IN VIVO INDUCTION OF HUMAN CYTOCHROME P450 ENZYMES EXPRESSED IN CHIMERIC MICE WITH HUMANIZED LIVER
      Miki Katoh, Tomohito Matsui, Miki Nakajima, Chise Tateno, Yoshinori Soeno, Toru Horie, Kazuhide Iwasaki, Katsutoshi Yoshizato and Tsuyoshi Yokoi
      Drug Metabolism and Disposition June 2005, 33 (6) 754-763; DOI: https://doi.org/10.1124/dmd.104.002600

Z

  1. Zhang, Yi

    1. You have access
      FUNCTIONAL ANALYSIS OF THE HUMAN VARIANTS OF BREAST CANCER RESISTANCE PROTEIN: I206L, N590Y, AND D620N
      R. Robert Vethanayagam, Honggang Wang, Anshul Gupta, Yi Zhang, Fred Lewis, Jashvant D. Unadkat and Qingcheng Mao
      Drug Metabolism and Disposition June 2005, 33 (6) 697-705; DOI: https://doi.org/10.1124/dmd.105.003657
  2. Zhang, Yifan

    1. You have access
      ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS
      Yingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui Zhou
      Drug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
  3. Zhao, Ping

    1. You have access
      EVALUATION OF TIME-DEPENDENT INACTIVATION OF CYP3A IN CRYOPRESERVED HUMAN HEPATOCYTES
      Ping Zhao, Kent L. Kunze and Caroline A. Lee
      Drug Metabolism and Disposition June 2005, 33 (6) 853-861; DOI: https://doi.org/10.1124/dmd.104.002832
  4. Zhao, Z.

    1. You have access
      METABOLIC ACTIVATION OF PIOGLITAZONE IDENTIFIED FROM RAT AND HUMAN LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTES
      T. M. Baughman, R. A. Graham, K. Wells-Knecht, I. S. Silver, L. O. Tyler, M. Wells-Knecht and Z. Zhao
      Drug Metabolism and Disposition June 2005, 33 (6) 733-738; DOI: https://doi.org/10.1124/dmd.104.002683
  5. Zhong, Dafang

    1. You have access
      ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS
      Yingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui Zhou
      Drug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
  6. Zhong, Hua

    1. You have access
      DETECTION OF A NOVEL REACTIVE METABOLITE OF DICLOFENAC: EVIDENCE FOR CYP2C9-MEDIATED BIOACTIVATION VIA ARENE OXIDES
      Zhengyin Yan, Jian Li, Norman Huebert, Gary W. Caldwell, Yanming Du and Hua Zhong
      Drug Metabolism and Disposition June 2005, 33 (6) 706-713; DOI: https://doi.org/10.1124/dmd.104.003095
  7. Zhou, Hui

    1. You have access
      ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS
      Yingjie Guo, Yifan Zhang, Ying Wang, Xiaoyan Chen, Dayong Si, Dafang Zhong, J. Paul Fawcett and Hui Zhou
      Drug Metabolism and Disposition June 2005, 33 (6) 749-753; DOI: https://doi.org/10.1124/dmd.105.003616
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 33 (6)
Drug Metabolism and Disposition
Vol. 33, Issue 6
1 Jun 2005
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics